MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NewAmsterdam Pharma (NAMS) Earnings Date & Reports
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more
A.I. Advisor
published Earnings
NAMS is expected to report earnings to fall 3.85% to -50 cents per share on November 04
Q3'26
Est.
$-0.50
Q2'26
Missed
by $0.04
Q1'26
Beat
by $0.09
Q4'25
Missed
by $0.23
Q3'25
Missed
by $0.21
The last earnings report on August 05 showed earnings per share of -51 cents, missing the estimate of -48 cents. With 412.73K shares outstanding, the current market capitalization sits at 2.57B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
100
Web
https://www.newamsterdampharma.com